Literature DB >> 28657211

Quality of life after bone sarcoma surgery around the knee: A long-term follow-up study.

W P Bekkering1,2, J C van Egmond-van Dam1, J A M Bramer2, A Beishuizen3, M Fiocco4, P D S Dijkstra1.   

Abstract

It remains unclear if quality of life (QoL) improvements could be expected in young patients after malignant bone tumour surgery after 2 years. To assess the course of QoL over time during a long-term follow-up, malignant bone tumour survivors of a previous short-term study were included. Assessments were done at least 5 years after surgery. QoL was measured with Short-form (SF)-36, TNO-AZL Questionnaire for Adult's Quality of Life (TAAQOL) and Bone tumour (Bt)-DUX. QoL throughout the follow-up was analysed by linear mixed model analysis. From the original cohort of 44 patients; 20 patients were included for this study, 10 males; mean age at surgery 15.1 years and mean follow-up 7.2 years. Twenty-one patients of the initial cohort (47%) deceased. Fifteen patients (75%) underwent limb-salvage and five (25%) ablative surgery. QoL improved significantly during follow-up at Physical Component Summary Scale scale of the SF-36 and TAAQOL and all subscales of the Bt-DUX (p < .01). No significant differences were found between current evaluations and previous evaluations at 2 years after surgery (p = .41-.98). Significant advantages after limb-salvage were seen at the PCS scale of the SF-36 (MD 13.7, p = .05) and the cosmetic scale of the Bt-DUX (MD 17.7, p = .04).
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  adolescents; children; leg; malignant bone tumour; prospective; quality of life

Mesh:

Year:  2016        PMID: 28657211     DOI: 10.1111/ecc.12603

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  7 in total

1.  Biology and technology in the surgical treatment of malignant bone tumours in children and adolescents, with a special note on the very young.

Authors:  Lizz van der Heijden; Germán L Farfalli; Inês Balacó; Cristina Alves; Marta Salom; José M Lamo-Espinosa; Mikel San-Julián; Michiel A J van de Sande
Journal:  J Child Orthop       Date:  2021-08-20       Impact factor: 1.548

2.  What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?

Authors:  Koichi Ogura; Mohamed A Yakoub; Alexander B Christ; Tomohiro Fujiwara; Zarko Nikolic; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2020-09       Impact factor: 4.755

Review 3.  A Critical Review of the Impact of Sarcoma on Psychosocial Wellbeing.

Authors:  Lesley Storey; Lorna A Fern; Ana Martins; Mary Wells; Lindsey Bennister; Craig Gerrand; Maria Onasanya; Jeremy S Whelan; Rachael Windsor; Julie Woodford; Rachel M Taylor
Journal:  Sarcoma       Date:  2019-02-17

4.  Qualitative study exploring patients experiences of being diagnosed and living with primary bone cancer in the UK.

Authors:  Ana Martins; Jeremy S Whelan; Lindsey Bennister; Lorna A Fern; Craig Gerrand; Maria Onasanya; Lesley Storey; Mary Wells; Rachael Windsor; Julie Woodford; Rachel M Taylor
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

5.  Body image, self-esteem, and quality of life in patients with primary malignant bone tumors.

Authors:  Lukas A Holzer; Nicolas Huyer; Jörg Friesenbichler; Andreas Leithner
Journal:  Arch Orthop Trauma Surg       Date:  2019-05-24       Impact factor: 3.067

6.  Cross-Cultural Validation of the Italian Version of the Bt-DUX: A Subjective Measure of Health-Related Quality of Life in Patients Who Underwent Surgery for Lower Extremity Malignant Bone Tumour.

Authors:  Mattia Morri; Peter Willem Bekkering; Marco Cotti; Matilde Meneghini; Enrico Venturini; Alessandra Longhi; Elisabetta Mariani; Cristiana Forni
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

7.  Minimal clinically important differences in SF-36 global score: Current value in orthopedic oncology.

Authors:  Koichi Ogura; Meredith K Bartelstein; Mohamed A Yakoub; Zarko Nikolic; Patrick J Boland; John H Healey
Journal:  J Orthop Res       Date:  2020-12-20       Impact factor: 3.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.